Oral semaglutide: an OASIS from injectables
- PMID: 37633662
- DOI: 10.1016/S0140-6736(23)01479-4
Oral semaglutide: an OASIS from injectables
Comment on
-
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial.Lancet. 2023 Aug 26;402(10403):705-719. doi: 10.1016/S0140-6736(23)01185-6. Epub 2023 Jun 26. Lancet. 2023. PMID: 37385278 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
